Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy

Clinical Cardiology

Volumn 23, Issue 5, 2000, Pages 365-370

  Shimizu, Masami ^a   Ino, Hidekazu ^a   Okeie, Kazuyasu ^a   Emoto, Yorito ^a   Yamaguchi, Masato ^a   Yasuda, Toshihiko ^a   Fujino, Noboru ^a   Fujii, Hiroyuki ^a   Fujita, Shinichiro ^a   Nakajima, Kenichi ^a   Taki, Junichi ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Asymmetric septal hypertrophy; Hypertension; Hypertrophic cardiomyopathy; Meta iodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE;

EID: 0034011234     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230512     Document Type: Article

References (33)

1. Abbasi AS, MacAlpin RN, Eber LM, Pearce ML: Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 1972;46:897-904
2. Henry WL, Clark CE, Epstein SE: Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973;47:225-233
3. Toshima H, Koga Y, Yoshioka H, Akiyoshi T, Kimura N: Echocardiographic classification of hypertensive heart disease. A correlative study with clinical features. Jpn Heart J 1975;16:377-393
4. Abi-samra F, Fouad FM, Tarazi RC: Determinants of left ventricular hypertrophy and function in hypertensive patients. An echocardiographic study. Am J Med 1983;75:26-33
5. Verdecchia P, Porcellati C, Zampi I, Schillaci G, Gatteschi C, Battistelli M, Bartoccini C, Borgioni C, Ciucci A: Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. Am J Cardiol 1994;73:247-252
6. Iida K, Sugishita Y, Matsuda M, Yamaguchi T, Ajisaka R, Matsumoto R, Fujita T, Yukisada K, Ito I: Difference in the response to isoproterenol between asymmetric septal hypertrophy and symmetric hypertrophy in patients with hypertrophic cardiomyopathy. Clin Cardiol 1986;9:7-12
7. Raum WJ, Laks MM, Garner D, Swerdloff RS: β-adrenergic receptor and cyclic AMP alterations in the canine ventricular septum during long-term norepinephrine infusion: Implications for hypertrophic eardiomyopathy. Circulation 1983;68:693-699
8. Bernardi D, Bernini L, Cini G, Ghione S, Bonechi I: Asymmetric septal hypertrophy and sympathetic overactivity in normotensive nemodialyzed patients. Am Heart J 1985:109:539-545
9. Brush JE Jr, Eisenhofer G, Garty M, Stull R, Maron BJ, Cannon RO III, Panza JA, Epstein SE, Goldstein DS: Cardiac norepinephrine kinetics in hypertrophic eardiomyopathy. Circulation 1989; 79:836-844
10. Schafers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG: Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic eardiomyopathy. Circ Res 1998;82:57-62
11. Simpson P, McGrath A: Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response. J Clin Invest 1983;72:732-738
12. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT: Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive eardiomyopathy. Circulation 1988;78:1192-1199
13. Nakajima K, Bunko H, Taki J, Shimizu M, Muramori A, Hisada K: Quantitative analysis of 1231-metaiodobenzylguanidine (MIBG) uptake in hypertrophic eardiomyopathy. Am Heart J 1990;119: 1329-1337
14. Brockenbrough EC, Braunwald E, Morrow AC: A hemodynamic technic for the detection of hypertrophic subaortic stenosis. Circulation 1961;23:189-194
15. Shimizu M, Sugihara N, Kita Y, Shimizu K, Horita Y, Nakajima K, Taki J, Takeda R: Long term course and cardiac sympathetic nerve activity in patients with hypertrophic eardiomyopathy. Br Heart J 1992;67:155-160
16. Maron BJ, Edwards JE, Ferrans VJ, Clark CE, Lebowitz EA, Henry WL, Epstein SE: Congenital heart malformations associated with disproportionate ventricular septal thickening. Circulation 1975;52:926-932
17. Abbasi AS, Slaughter JC, Allen MW: Asymmetric septal hypertrophy in patients on long-term hemodialysis. Chest 1978;74:548-551
18. Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP: Asymmetric septal hypertrophy in patients with aortic stenosis: An adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? J Am Coll Cardiol 1983;1:783-789
19. Karam R, Lever HM, Healy BP: Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 1989;13:580-584
20. Kawai C, Yui Y, Hoshino T, Sasayama S, Matsumori A: Myocardial catecholamine in hypertrophic and dilated (congestive) cardiomyopathy: A biopsy study. J Am Coll Cardiol 1983;2:834-840
21. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A: Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-477
22. Lefroy DC, Silva R, Choudhury L, Uren NG, Crake T, Rhodes CG, Lammertsma AA, Boyd H, Patsalos PN, Nihoyannopoulos P, Oakley CM, Jones T, Camici PG: Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography. J Am Coll Cardiol 1993;22: 1653-1660
23. Nakajima K, Taki J, Tonami N, Hisada K: Decreased 123 I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994;15:317-323
24. Tazelaar HD, Billingham ME: The surgical pathology of hypertrophic cardiomyopathy. Arch Pathol Lab Med 1987;111:257-260
25. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GH, Stewart JA, Chen LF, Castilla EP, Gomez AA, Abrahamowicz M: A method of dynamic analysis of iodine-123-metaiodobenzyl-guanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993;34:589-600
26. Mitani I, Sumita S, Takahashi N, Ochiai H, Ishii M: 123 I-MIBG myocardial imaging in hypertensive patients: Abnormality progresses with left ventricular hypertrophy. Ann Nucl Med 1996;10: 315-321
27. Morimoto S, Terada K, Keira N, Satoda M, Inoue K, Talsukawa H, Katoh S, Ida K, Sugihara H, Takeda K, Nakagawa M: Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging. Eur J Nucl Med 1996;23:756-761
28. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG: A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006
29. Schwartz K, Carrier L, Guicheney P, Komajda M: Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-540
30. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE: α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994:77:701-712
31. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet 1997;16:379-382
32. Carrier L, Bonne G, Bahrend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagege AA, Trent RJ, Komajda M, Fiszman M, Schwarz K: Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997;80:427-434
33. Ungerer M, Hartmann F, Karoglan M, Chlistalla A, Ziegler S, Richardt G, Overbeck M, Meisner H, Schomig A, Schwaiger M: Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 1998;97: 174-180